Stock Market Blog
Daily stock market analysis, trade alerts, and trading education from Ross Givens and the Traders Agency team.
Options Strategy Selection: How to Pick the Right Trade
Learn how to choose options strategy using direction, volatility, risk, and capital—so you stop guessing and start trading with a plan.
A Once-in-a-Generation Commodity Boom Is HERE… I'm Buying THESE 2 Stocks
Commodity boom stocks are heating up as gold and copper supply gaps widen. See the 2 picks playing both sides of this once-in-a-generation shift.
Tesla Unveils Thruster-Equipped Next-Generation Roadster at SpaceX Site, Targets 2028 Production With No Price Set
Tesla unveiled a thruster-equipped next-generation Roadster at a SpaceX test site in Texas, targeting 2028 production. No retail price was disclosed, street-legal status is unresolved, and analysts say the car is unlikely to move Tesla's financials.
Labcorp to Acquire BioReference Health Clinical, Women's Health and Urology Testing Assets From OPKO for $722 Million
Labcorp has agreed to acquire BioReference Health's clinical, women's health, urology and corrections testing assets from OPKO Health for $722 million in cash plus up to $150 million tied to 4Kscore revenue, pending regulatory approval.
CMA Proposes Designating Microsoft With Strategic Market Status in UK Business Software
The CMA has provisionally found Microsoft meets the statutory conditions for strategic market status in its UK business software ecosystem, covering Windows, Microsoft 365, Copilot, security and server products, with consultation responses due 13 November 2026 and a final decision by 13 February 2027.
Why Most YOLO Plays Fail: Position Sizing and Risk Management
Why YOLO plays fail: learn position sizing and risk management, the 1% rule, and how to calculate position size before your next trade.
Some Anthropic Investors Push for $1.5 Trillion IPO Valuation as Q3 Revenue Growth Cools to 45%
Some Anthropic investors are weighing a roughly $1.5 trillion IPO valuation, down from the $2 trillion previously floated, after the AI company disclosed Q3 revenue growth of 45% sequentially to $16.8 billion, Reuters reported.
CHMP Recommends EU Approval of Lilly's Oral GLP-1 Pill Foundayo for Obesity and Type 2 Diabetes
EMA's CHMP has recommended EU marketing authorisation for Eli Lilly's oral GLP-1 pill Foundayo (orforglipron) for weight management and type 2 diabetes, pending a European Commission decision.
MSCI Proposal to Strip Indonesia of Emerging-Market Status Triggers Jakarta's Worst Stock Drop Since 1998
MSCI's proposal to reclassify Indonesia as a standalone market triggered the steepest one-day Jakarta stock drop since 1998, with brokers estimating billions in potential outflows as regulators and the central bank moved to steady markets.
Big Stock Swings Incoming?
Earnings news and thinner trading could amplify individual-stock swings. Ross explains where he’s looking for positive catalysts.
Proofpoint Agrees to Buy Varonis Systems for $6.3 Billion in Cash at $49.75 a Share
Thoma Bravo-owned Proofpoint has agreed to acquire Varonis Systems for about $6.3 billion in cash at $49.75 per share, a deal reported as expected to close in the first half of 2027.
Stop watching.
Start winning.
50,000+ traders get our daily brief before the market opens.
You're subscribed!
Check your inbox.
Free. No spam. Unsubscribe anytime.
